EPGNF OTC
Epigenomics AG
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: +72.3%
5Y: -17.0%
$1.12
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.0M
52W Range0.79-1.12
Volume0
Avg Volume556
Beta0.87
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJason Wouhra
Employees3
SectorHealthcare
IndustryMedical - Specialties
IPO Date2010-12-31
Websiteepigenomics.com
ZiegelhAeuser Landstrasse 3
Heidelberg, BE 69120
DE
Heidelberg, BE 69120
DE
49 30 243 450
About Epigenomics AG
Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. It offers Epi proColon, a blood-based test for the early detection of colorectal cancer; Epi proLung, a confirmatory test that aids in the diagnosis of lung cancer, Epi BiSKit, a kit for the preparation of purified, bisulfite-converted DNA and, HCCBloodTest, a blood test for cirrhotic patients at high-risk for the development of hepatocellular carcinoma. The company was founded by Oliver Schacht, Christian Piepenbrock, Kurt Berlin, Jörn Walter, and Ivo G. Gut in 1998 and is headquartered in Berlin, Germany.
Latest News
No recent news
Recent Insider Trades
No insider trades found